Israelis pay one of the OECD’s most modest mandatory health-insurance contributions. The OECD’s Health at a Glance 2025 country note puts Israel’s mandatory prepayment share of total health expenditure at 62 percent, against an OECD average of 75 percent. The remaining 38 percent moves through supplementary insurance and direct out-of-pocket spending, and that 38 percent has expanded almost every year for a decade.

The growth is not evenly distributed. The Taub Center’s 2024 health system update reports that private funding rose to 34.8 percent of national health expenditure in 2023, up from 33.9 percent the year before. Earlier Taub work tracked household private spending climbing from roughly NIS 2,247 a year in 1995 to NIS 3,634 by 2014, in 2014 prices. The share of household budgets going to health rose from 3.9 to 5.9 percent over the same window, and the share of Israelis carrying supplementary insurance climbed from 50 to 80 percent.

The Public Basket Has A Hard Edge

The Israeli health basket is generous at the entry point and selective at the edges. Adults aged 19 to 74 fall almost entirely outside its dental coverage, which formally extends only to children and to residents 75 and older. A 2025 BMC Public Health study on the older-adult dental reform notes that the 2019 expansion to ages 75 and up was the first material widening of adult dental access since the 2010 reform that began with children.

Refractive vision correction is not in the basket. Most fast-track surgical scheduling is not in the basket. The Commonwealth Fund’s Israel system profile records that bariatric, fertility, and several psychological services are partially included, with material co-pays or condition-based gating.

That edge is where Israeli households now meet the consumer-finance economy. Adjacent strain on the delivery side, including the workforce-modernization gap covered in this publication’s earlier reporting, sits one layer behind the cost burden households feel first.

Supplementary Insurance Filled One Gap

Roughly four out of five Israelis carry voluntary health insurance through their kupat holim or a commercial insurer. The Euro Health Observatory’s reform record documents both the scale of VHI penetration and the regulatory tightening that took effect in March 2024, when commercial insurers were prohibited from selling overlapping surgical coverage that duplicated kupat holim policies.

The supplementary layer has its own cost trajectory. The WHO European Observatory’s Israel system review records that private health expenditure as a share of total national health spending rose from 8.2 percent in 2010 to 11.1 percent in 2018, with roughly three-quarters of that increase attributable to commercial VHI premiums rather than direct out-of-pocket payments. Premiums are a fixed monthly cost. The treatments they do not cover, or that come with deductibles, annual ceilings, or waiting periods, are not.

Taub Center researchers describe the consequence in plain terms: the increased role of private spending “confounds the notion of equal access to some extent,” with weaker population groups spending a greater share of their income on private health expenditures than wealthier ones.

A Financing Layer Has Followed The Cash Burden

Where supplementary insurance does not close the gap, household credit fills it. In the United States, installment-based payment models (fixed monthly-payment products originated at the point of care, used most heavily in dental, orthodontic, vision, hearing, aesthetic, and veterinary practices) have grown into a multi-billion-dollar layer of healthcare consumer finance. The category sits alongside medical credit cards and hospital payment plans, and it now plays a documented role in U.S. patient access to elective and dental procedures.

The same product mechanics fit Israeli specialty clinics directly. Adult dental, refractive vision, aesthetic, and elective surgical procedures all originate inside private practices that bill the patient before any insurance reimbursement closes the loop. The clinical setting, the cost-at-decision timing, and the underwriting profile match the conditions the financing category was built around.

The infrastructure to host the category domestically is in place. Israel’s fintech revival has produced point-of-sale financing networks, multi-lender underwriting engines, and consumer-credit data infrastructure across adjacent retail verticals. The matching engines that originate furniture and electronics loans at checkout run on the same architecture as the U.S. patient-financing market; pricing a dental restoration through those rails is mechanically trivial.

What Regulators Have Already Flagged

The U.S. experience offers a forward-looking record Israeli regulators can read. The Consumer Financial Protection Bureau’s 2023 medical credit cards report found that consumers paid approximately $1 billion in deferred interest charges between 2018 and 2020, and that medical specialty financing products carried interest rates above 25 percent on average. The bureau’s central concern was the distribution channel: many products were originated at the point of care, often before patients had been screened for hospital financial assistance or insurance coverage they already qualified for.

That distribution profile has direct relevance for Israeli specialty practices, which already operate at the boundary of the public basket. The Israeli Capital Markets, Insurance and Savings Authority has not issued category-specific guidance on point-of-care medical financing. The closest precedent is the same regulator’s 2024 surgical-VHI reform, which addressed a parallel concern: layered private products sold inside a market patients cannot easily price-compare.

What The Numbers Suggest Next

Three variables will shape the next phase. The first is the trajectory of the private-share figure. If Taub’s next annual update shows the 34.8 percent reading drifting toward 36 or 37 percent, the supplementary layer and out-of-pocket spending are continuing to absorb growth that mandatory prepayment is not picking up. The second is basket policy. The 2019 dental reform’s extension to ages 75 and up was specific. Whether the 19-to-74 cohort sees similar movement is open. The third is product migration. Installment-based financing, with its disclosure rules and deferred-interest mechanics, is scaling against an Israeli regulatory perimeter that has not yet been drawn around it.

Adults aged 19 to 74 remain outside the basket’s dental coverage. The treatments their households still need are increasingly priced and financed through twelve and twenty-four month installments. The mandatory layer of Israel’s health system is 62 percent of total health expenditure. The other 38 percent is where the next market opens.